Tags

Type your tag names separated by a space and hit enter

Scientific research progress of COVID-19/SARS-CoV-2 in the first five months.
J Cell Mol Med. 2020 06; 24(12):6558-6570.JC

Abstract

A cluster of pneumonia (COVID-19) cases have been found in Wuhan China in late December, 2019, and subsequently, a novel coronavirus with a positive stranded RNA was identified to be the aetiological virus (severe acute respiratory syndrome coronavirus 2, SARS-CoV-2), which has a phylogenetic similarity to severe acute respiratory syndrome coronavirus (SARS-CoV). SARS-CoV-2 transmits mainly through droplets and close contact and the elder or people with chronic diseases are high-risk population. People affected by SARS-CoV-2 can be asymptomatic, which brings about more difficulties to control the transmission. COVID-19 has become pandemic rapidly after onset, and so far the infected people have been above 2 000 000 and more than 130 000 died worldwide according to COVID-19 situation dashboard of World Health Organization (https://covid19.who.int). Here, we summarized the current known knowledge regarding epidemiological, pathogenesis, pathology, clinical features, comorbidities and treatment of COVID-19/ SARS-CoV-2 as reference for the prevention and control COVID-19.

Authors+Show Affiliations

Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Shanghai Xuhui District Central Hospital and Zhongshan-Xuhui Hospital, Zhongshan Hospital, Fudan University, Shanghai, China.Department of Medicine, BestNovo (Beijing) Medical Technology Co., Ltd, Beijing, China.Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Shanghai Xuhui District Central Hospital and Zhongshan-Xuhui Hospital, Zhongshan Hospital, Fudan University, Shanghai, China.

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't
Review

Language

eng

PubMed ID

32320516

Citation

Li, Hua, et al. "Scientific Research Progress of COVID-19/SARS-CoV-2 in the First Five Months." Journal of Cellular and Molecular Medicine, vol. 24, no. 12, 2020, pp. 6558-6570.
Li H, Liu Z, Ge J. Scientific research progress of COVID-19/SARS-CoV-2 in the first five months. J Cell Mol Med. 2020;24(12):6558-6570.
Li, H., Liu, Z., & Ge, J. (2020). Scientific research progress of COVID-19/SARS-CoV-2 in the first five months. Journal of Cellular and Molecular Medicine, 24(12), 6558-6570. https://doi.org/10.1111/jcmm.15364
Li H, Liu Z, Ge J. Scientific Research Progress of COVID-19/SARS-CoV-2 in the First Five Months. J Cell Mol Med. 2020;24(12):6558-6570. PubMed PMID: 32320516.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Scientific research progress of COVID-19/SARS-CoV-2 in the first five months. AU - Li,Hua, AU - Liu,Zhe, AU - Ge,Junbo, Y1 - 2020/05/07/ PY - 2020/04/15/received PY - 2020/04/19/revised PY - 2020/04/22/accepted PY - 2020/4/23/pubmed PY - 2020/7/1/medline PY - 2020/4/23/entrez SP - 6558 EP - 6570 JF - Journal of cellular and molecular medicine JO - J Cell Mol Med VL - 24 IS - 12 N2 - A cluster of pneumonia (COVID-19) cases have been found in Wuhan China in late December, 2019, and subsequently, a novel coronavirus with a positive stranded RNA was identified to be the aetiological virus (severe acute respiratory syndrome coronavirus 2, SARS-CoV-2), which has a phylogenetic similarity to severe acute respiratory syndrome coronavirus (SARS-CoV). SARS-CoV-2 transmits mainly through droplets and close contact and the elder or people with chronic diseases are high-risk population. People affected by SARS-CoV-2 can be asymptomatic, which brings about more difficulties to control the transmission. COVID-19 has become pandemic rapidly after onset, and so far the infected people have been above 2 000 000 and more than 130 000 died worldwide according to COVID-19 situation dashboard of World Health Organization (https://covid19.who.int). Here, we summarized the current known knowledge regarding epidemiological, pathogenesis, pathology, clinical features, comorbidities and treatment of COVID-19/ SARS-CoV-2 as reference for the prevention and control COVID-19. SN - 1582-4934 UR - https://www.unboundmedicine.com/medline/citation/32320516/Scientific_research_progress_of_COVID_19/SARS_CoV_2_in_the_first_five_months_ L2 - https://doi.org/10.1111/jcmm.15364 DB - PRIME DP - Unbound Medicine ER -